GB201703809D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
GB201703809D0
GB201703809D0 GBGB1703809.2A GB201703809A GB201703809D0 GB 201703809 D0 GB201703809 D0 GB 201703809D0 GB 201703809 A GB201703809 A GB 201703809A GB 201703809 D0 GB201703809 D0 GB 201703809D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1703809.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Treos Bio Kft
Original Assignee
Treos Bio Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Treos Bio Kft filed Critical Treos Bio Kft
Priority to GBGB1703809.2A priority Critical patent/GB201703809D0/en
Publication of GB201703809D0 publication Critical patent/GB201703809D0/en
Priority to EP18707724.3A priority patent/EP3589954A1/en
Priority to CN201880014739.4A priority patent/CN110621334A/en
Priority to CA3054861A priority patent/CA3054861A1/en
Priority to JP2019568814A priority patent/JP2020514413A/en
Priority to EP18710392.4A priority patent/EP3589951A1/en
Priority to BR112019018313A priority patent/BR112019018313A2/en
Priority to CN201880014727.1A priority patent/CN110651188B/en
Priority to JP2019568816A priority patent/JP7437939B2/en
Priority to IL268919A priority patent/IL268919B2/en
Priority to SG11201906765UA priority patent/SG11201906765UA/en
Priority to AU2018228785A priority patent/AU2018228785A1/en
Priority to EA201992059A priority patent/EA201992059A1/en
Priority to AU2018228786A priority patent/AU2018228786A1/en
Priority to MX2019010461A priority patent/MX2019010461A/en
Priority to PCT/EP2018/055232 priority patent/WO2018158457A1/en
Priority to EA201992057A priority patent/EA201992057A1/en
Priority to AU2018226566A priority patent/AU2018226566A1/en
Priority to MA047678A priority patent/MA47678A/en
Priority to PCT/EP2018/055231 priority patent/WO2018158456A1/en
Priority to CA3054871A priority patent/CA3054871A1/en
Priority to SG11201907402SA priority patent/SG11201907402SA/en
Priority to EP18707725.0A priority patent/EP3589310A1/en
Priority to MA047683A priority patent/MA47683A/en
Priority to BR112019018312-4A priority patent/BR112019018312A2/en
Priority to MX2019010459A priority patent/MX2019010459A/en
Priority to US15/910,965 priority patent/US20180264095A1/en
Priority to KR1020197029094A priority patent/KR102591136B1/en
Priority to EA201992058A priority patent/EA201992058A1/en
Priority to CN201880014745.XA priority patent/CN110651189A/en
Priority to KR1020197029092A priority patent/KR102549625B1/en
Priority to SG11201907524UA priority patent/SG11201907524UA/en
Priority to PCT/EP2018/055230 priority patent/WO2018158455A1/en
Priority to US15/910,988 priority patent/US10213497B2/en
Priority to BR112019018307-8A priority patent/BR112019018307A2/en
Priority to JP2019568815A priority patent/JP2020510698A/en
Priority to MA047677A priority patent/MA47677A/en
Priority to MX2019010460A priority patent/MX2019010460A/en
Priority to CA3054866A priority patent/CA3054866A1/en
Priority to US15/910,930 priority patent/US20180264094A1/en
Priority to KR1020197029093A priority patent/KR20190133177A/en
Priority to US16/244,497 priority patent/US11213578B2/en
Priority to ZA2019/04723A priority patent/ZA201904723B/en
Priority to ZA2019/04725A priority patent/ZA201904725B/en
Priority to IL26892019A priority patent/IL268920A/en
Priority to IL268917A priority patent/IL268917B2/en
Priority to CL2019002534A priority patent/CL2019002534A1/en
Priority to CL2019002533A priority patent/CL2019002533A1/en
Priority to CL2019002532A priority patent/CL2019002532A1/en
Priority to CONC2019/0010524A priority patent/CO2019010524A2/en
Priority to CONC2019/0010503A priority patent/CO2019010503A2/en
Priority to CONC2019/0010698A priority patent/CO2019010698A2/en
Priority to US17/448,020 priority patent/US20220031823A1/en
Priority to US17/454,225 priority patent/US20220072114A1/en
Priority to US17/645,737 priority patent/US11426452B2/en
Priority to US17/645,741 priority patent/US11628211B2/en
Priority to CL2022002836A priority patent/CL2022002836A1/en
Priority to JP2022197534A priority patent/JP2023051941A/en
Priority to US18/166,420 priority patent/US20230405100A1/en
Ceased legal-status Critical Current

Links

GBGB1703809.2A 2017-03-03 2017-03-09 Vaccine Ceased GB201703809D0 (en)

Priority Applications (59)

Application Number Priority Date Filing Date Title
GBGB1703809.2A GB201703809D0 (en) 2017-03-09 2017-03-09 Vaccine
EP18707724.3A EP3589954A1 (en) 2017-03-03 2018-03-02 Peptide vaccines
CN201880014739.4A CN110621334A (en) 2017-03-03 2018-03-02 Personalized immunogenic peptide identification platform
CA3054861A CA3054861A1 (en) 2017-03-03 2018-03-02 Peptide vaccines
JP2019568814A JP2020514413A (en) 2017-03-03 2018-03-02 Peptide vaccine
EP18710392.4A EP3589951A1 (en) 2017-03-03 2018-03-02 Population-based immunogenic peptide identification platform
BR112019018313A BR112019018313A2 (en) 2017-03-03 2018-03-02 peptide vaccines
CN201880014727.1A CN110651188B (en) 2017-03-03 2018-03-02 Population-based immunogenic peptide identification platform
JP2019568816A JP7437939B2 (en) 2017-03-03 2018-03-02 A platform for population-based immunogenic peptide identification
IL268919A IL268919B2 (en) 2017-03-03 2018-03-02 Personalised immunogenic peptide identification platform
SG11201906765UA SG11201906765UA (en) 2017-03-03 2018-03-02 Personalised immunogenic peptide identification platform
AU2018228785A AU2018228785A1 (en) 2017-03-03 2018-03-02 Peptide vaccines
EA201992059A EA201992059A1 (en) 2017-03-09 2018-03-02 PLATFORM FOR IDENTIFICATION OF IMMUNOGENOUS PEPTIDES OF THE POPULATION LEVEL
AU2018228786A AU2018228786A1 (en) 2017-03-03 2018-03-02 Personalised immunogenic peptide identification platform
MX2019010461A MX2019010461A (en) 2017-03-03 2018-03-02 Personalised immunogenic peptide identification platform.
PCT/EP2018/055232 WO2018158457A1 (en) 2017-03-03 2018-03-02 Population-based immunogenic peptide identification platform
EA201992057A EA201992057A1 (en) 2017-03-09 2018-03-02 PERSONALIZED PLATFORM FOR IDENTIFICATION OF AN IMMUNOGENOUS PEPTIDE
AU2018226566A AU2018226566A1 (en) 2017-03-03 2018-03-02 Population-based immunogenic peptide identification platform
MA047678A MA47678A (en) 2017-03-03 2018-03-02 PERSONALIZED IMMUNOGENIC PEPTIDE IDENTIFICATION PLATFORM
PCT/EP2018/055231 WO2018158456A1 (en) 2017-03-03 2018-03-02 Personalised immunogenic peptide identification platform
CA3054871A CA3054871A1 (en) 2017-03-03 2018-03-02 Population-based immunogenic peptide identification platform
SG11201907402SA SG11201907402SA (en) 2017-03-03 2018-03-02 Population-based immunogenic peptide identification platform
EP18707725.0A EP3589310A1 (en) 2017-03-03 2018-03-02 Personalised immunogenic peptide identification platform
MA047683A MA47683A (en) 2017-03-03 2018-03-02 POPULATION-BASED IMMUNOGEN PEPTIDE IDENTIFICATION PLATFORM
BR112019018312-4A BR112019018312A2 (en) 2017-03-03 2018-03-02 CUSTOMIZED IMMUNOGENIC PEPTIDE IDENTIFICATION PLATFORM
MX2019010459A MX2019010459A (en) 2017-03-03 2018-03-02 Peptide vaccines.
US15/910,965 US20180264095A1 (en) 2017-03-03 2018-03-02 Population-based immunogenic peptide identification platform
KR1020197029094A KR102591136B1 (en) 2017-03-03 2018-03-02 Population-based immunogenic peptide identification platform
EA201992058A EA201992058A1 (en) 2017-03-09 2018-03-02 VACCINE
CN201880014745.XA CN110651189A (en) 2017-03-03 2018-03-02 Peptide vaccine
KR1020197029092A KR102549625B1 (en) 2017-03-03 2018-03-02 Personalized Immunogenic Peptide Identification Platform
SG11201907524UA SG11201907524UA (en) 2017-03-03 2018-03-02 Peptide vaccines
PCT/EP2018/055230 WO2018158455A1 (en) 2017-03-03 2018-03-02 Peptide vaccines
US15/910,988 US10213497B2 (en) 2017-03-03 2018-03-02 Vaccine
BR112019018307-8A BR112019018307A2 (en) 2017-03-03 2018-03-02 PLATFORM FOR IDENTIFICATION OF IMMUNOGENIC PEPTIDES BASED ON POPULATION
JP2019568815A JP2020510698A (en) 2017-03-03 2018-03-02 Platform for identification of individualized immunogenic peptides
MA047677A MA47677A (en) 2017-03-03 2018-03-02 PEPTIDIC VACCINES
MX2019010460A MX2019010460A (en) 2017-03-03 2018-03-02 Population-based immunogenic peptide identification platform.
CA3054866A CA3054866A1 (en) 2017-03-03 2018-03-02 Personalised immunogenic peptide identification platform
US15/910,930 US20180264094A1 (en) 2017-03-03 2018-03-02 Personalised immunogenic peptide identification platform
KR1020197029093A KR20190133177A (en) 2017-03-03 2018-03-02 Peptide Vaccine
US16/244,497 US11213578B2 (en) 2017-03-03 2019-01-10 Vaccine
ZA2019/04723A ZA201904723B (en) 2017-03-03 2019-07-18 Population-based immunogenic peptide identification platform
ZA2019/04725A ZA201904725B (en) 2017-03-03 2019-07-18 Personalised immunogenic peptide identification platform
IL26892019A IL268920A (en) 2017-03-03 2019-08-26 Peptide vaccines
IL268917A IL268917B2 (en) 2017-03-03 2019-08-26 Population-based immunogenic peptide identification platform
CL2019002534A CL2019002534A1 (en) 2017-03-03 2019-09-03 Custom immunogenic peptide identification platform.
CL2019002533A CL2019002533A1 (en) 2017-03-03 2019-09-03 Vaccine.
CL2019002532A CL2019002532A1 (en) 2017-03-03 2019-09-03 Population-based immunogenic peptide identification platform.
CONC2019/0010524A CO2019010524A2 (en) 2017-03-03 2019-09-26 Population-based immunogenic peptide identification platform
CONC2019/0010503A CO2019010503A2 (en) 2017-03-03 2019-09-26 Custom immunogenic peptide identification platform
CONC2019/0010698A CO2019010698A2 (en) 2017-03-03 2019-09-27 Peptide vaccines
US17/448,020 US20220031823A1 (en) 2017-03-03 2021-09-17 Personalised immunogenic peptide identification platform
US17/454,225 US20220072114A1 (en) 2017-03-03 2021-11-09 Population-based immunogenic peptide identification platform
US17/645,737 US11426452B2 (en) 2017-03-03 2021-12-22 Vaccine
US17/645,741 US11628211B2 (en) 2017-03-03 2021-12-22 Vaccine
CL2022002836A CL2022002836A1 (en) 2017-03-03 2022-10-14 Cancer-derived polypeptides (divisional 201902533)
JP2022197534A JP2023051941A (en) 2017-03-03 2022-12-09 peptide vaccine
US18/166,420 US20230405100A1 (en) 2017-03-03 2023-02-08 Vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1703809.2A GB201703809D0 (en) 2017-03-09 2017-03-09 Vaccine

Publications (1)

Publication Number Publication Date
GB201703809D0 true GB201703809D0 (en) 2017-04-26

Family

ID=58605461

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1703809.2A Ceased GB201703809D0 (en) 2017-03-03 2017-03-09 Vaccine

Country Status (2)

Country Link
EA (3) EA201992059A1 (en)
GB (1) GB201703809D0 (en)

Also Published As

Publication number Publication date
EA201992059A1 (en) 2020-03-31
EA201992057A1 (en) 2020-03-06
EA201992058A1 (en) 2020-03-12

Similar Documents

Publication Publication Date Title
GB201410971D0 (en) Vaccine
GB201518684D0 (en) Vaccine
PL3185899T3 (en) Improved hvt-vectored nd-ibd vaccine
IL271558B1 (en) Personalized vaccine
GB201522132D0 (en) Vaccine
GB201616007D0 (en) Novel Adjuvants
SG11202004899SA (en) Lassa vaccine
GB201506041D0 (en) Avian vaccine
GB2562241B (en) Vaccine compositions
GB201616904D0 (en) Vaccine
IL267264A (en) Adjuvants
GB201703529D0 (en) Vaccine composition
GB201608821D0 (en) Vaccines
RS61000B1 (en) Vaccine
GB201811382D0 (en) Vaccine
EP3706787A4 (en) Vaccine
GB201718251D0 (en) Vaccine Compositions
GB201621375D0 (en) Adjuvants
GB201618479D0 (en) Adjuvants
GB201417214D0 (en) Vaccine
GB201712904D0 (en) Vaccine
GB201704126D0 (en) Vaccine
GB201703809D0 (en) Vaccine
GB201707785D0 (en) Vaccination
GB201706798D0 (en) Vaccination

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)